No Data
No Data
Sparx Hockey Acquires 20th International Patent Reinforcing Its Technology Leadership Position In Skate Sharpening
Pioneer of Automated, At-Home Skate Sharpening Solidifies Its Position As The No. 1 Brand in Skate Sharpening With Innovative Alignment Patent That Allows The Sparx Sharpener To Achieve Unmatched Acc
Express News | CalciMedica Presents Data From Preclinical Studies Of Auxora On Acute Kidney Injury At 29th International AKI & CRRT Conference
Tonix Pharmaceuticals Reports Improvement in "Brain Fog," in Fibromyalgia Patients Treated With Tonmya in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia
Tonix Pharmaceuticals Reports Improvement in "Brain Fog," in Fibromyalgia Patients Treated with Tonmya in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Contro
Express News | Senseonics Holdings Announces Data From Eversense Post Approval Study To Be Presented At 17th International Conference On Advanced Technologies And Treatments for Diabetes
Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes
Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today
Insulet to Present Results From First Omnipod 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
Conducted in the United States and France, the OP5-003 Trial is the first Omnipod 5 study to include international participants. The OP5-003 Trial Presentation and Insulet Symposium will convey the importance of
No Data